IPQ Inside the global regulatory dialogue

IPQ Monthly Update – July/August 2020 in Review

Sep 22nd, 2020

Please Log in to print the full article

The first story provides thought-provoking insights from Jeff Galvin, the CEO of California-based American Gene Technologies (AGT), on the implications of the design-based development paradigm and therapeutic power that comes into play for cell and gene therapies....

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications